JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 2, 2005; DOI: 10.1124/jpet.104.082388


0022-3565/05/3132-909-915$20.00
JPET 313:909-915, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.082388v1
313/2/909    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scheidweiler, K. B.
Right arrow Articles by Huestis, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scheidweiler, K. B.
Right arrow Articles by Huestis, M. A.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Dose-Related Distribution of Codeine, Cocaine, and Metabolites into Human Hair following Controlled Oral Codeine and Subcutaneous Cocaine Administration

Karl B. Scheidweiler, Edward J. Cone, Eric T. Moolchan, and Marilyn A. Huestis

Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland (K.B.S., E.T.M., M.A.H.); and ConeChem Research, LLC, Severna Park, Maryland (E.J.C.)

Hair testing for the determination of drug exposure has many useful applications. Drug incorporated into hair can be found for extended periods following drug exposure. There are few controlled drug administration studies investigating drug distribution into human hair. Ten volunteers participated in a 10-week controlled cocaine and codeine administration study while residing in the secure research ward. Weekly hair samples were collected by electric razor. During the low-dose week (week 4), volunteers received 75 mg/70 kg cocaine subcutaneously and 60 mg/70 kg codeine orally on alternating days, a total of three doses for each drug. Similarly, during week 7, volunteers received three doses 150 mg/70 kg cocaine and 120 mg/70 kg codeine. Maximum hair concentrations (Cmax) were found 1 to 3 weeks after low and high doses. Dose-related Cmax values of cocaine, benzoylecgonine, ecgonine methyl ester, norcocaine, cocaethylene, and codeine were found following low and high doses. Hair analysis was performed using liquid chromatography tandem mass spectrometry. A positive linear relationship was found between total melanin content of hair and Cmax of codeine, cocaine, and metabolites following high dosing. This study demonstrated dose-related concentrations of cocaine and metabolites in human hair following controlled cocaine administration. These data are the first demonstrating melanin-related incorporation of cocaine and metabolites into human hair following controlled cocaine administration.


Received for publication December 16, 2004
Accepted February 22, 2005.

Address correspondence to: Dr. Marilyn A. Huestis, Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, 5500 Nathan Shock Dr., Baltimore, MD 21224. E-mail: mhuestis{at}intra.nida.nih.gov




This article has been cited by other articles:


Home page
Alcohol AlcoholHome page
V. Kulaga, Y. Velazquez-Armenta, K. Aleksa, Z. Vergee, and G. Koren
The Effect of Hair Pigment on the Incorporation of Fatty Acid Ethyl Esters (FAEE)
Alcohol Alcohol., May 1, 2009; 44(3): 287 - 292.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. S. Goodwin, D. G. Wilkins, O. Averin, R. E. Choo, J. R. Schroeder, D. R. Jasinski, R. E. Johnson, H. E. Jones, and M. A. Huestis
Buprenorphine and Norbuprenorphine in Hair of Pregnant Women and Their Infants after Controlled Buprenorphine Administration
Clin. Chem., December 1, 2007; 53(12): 2136 - 2143.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.